A sweet outlook for Capilano Honey
In 2Q17, CZZ will launch a new high margin honey product. We understand that it is an innovative 'industry-first' therapeutic product which offers health benefits beyond those of regular honey. This product will be exclusive to CZZ. It should increase CZZ's overall market share, expand the honey category and has great potential in China. Importantly, for the first time in many years, CZZ will actively market this new product. CZZ recently acquired additional beekeeping enterprises and other licensed apiary sites. With these acquisitions, there is also the opportunity to materially grow production over time. We rate this company highly and believe CZZ is attractively priced when compared to its peers. Capilano Honey is household brand and market leader in a high margin, growth category. Read more to see why we’ve upgraded Capilano to an ‘Add’ rating with an increased share price target. (VIEW LINK)
Morgans is Australia's largest national full-service retail stockbroking and wealth management network with over 240,000 client accounts, 500 authorised representatives and 950 employees operating from offices in all states and territories.